An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 15014061)

Published in J Antimicrob Chemother on March 10, 2004

Authors

Rodrigo Alonso, Marc Galimand, Patrice Courvalin

Articles citing this

Rapid screening of topoisomerase gene mutations by a novel melting curve analysis method for early warning of fluoroquinolone-resistant Streptococcus pneumoniae emergence. J Clin Microbiol (2006) 1.11

Rapid detection of a point mutation in the parC gene associated with decreased susceptibility to fluoroquinolones in Mycoplasma bovis. Antimicrob Agents Chemother (2009) 0.96

Rapid screening of fluoroquinolone resistance determinants in Streptococcus pneumoniae by PCR-restriction fragment length polymorphism and single-strand conformational polymorphism. J Clin Microbiol (2006) 0.93

Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal. Antimicrob Agents Chemother (2010) 0.87

Pneumococci can persistently colonize adult patients with chronic respiratory disease. J Clin Microbiol (2012) 0.86

Prevalence of first-step mutants among levofloxacin-susceptible invasive isolates of Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother (2006) 0.85

Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain. Emerg Infect Dis (2014) 0.82

A rapid antimicrobial susceptibility test for Bacillus anthracis. Antimicrob Agents Chemother (2010) 0.81

New real-time PCR assay using locked nucleic acid probes to assess prevalence of ParC mutations in fluoroquinolone-susceptible Streptococcus pneumoniae isolates from France. Antimicrob Agents Chemother (2006) 0.80

Articles by these authors

Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis (2007) 3.98

Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95

Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother (2003) 3.22

Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother (2004) 2.89

Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob Agents Chemother (2007) 2.67

Modes and modulations of antibiotic resistance gene expression. Clin Microbiol Rev (2007) 2.66

ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum beta-lactamase CTX-M-17. Antimicrob Agents Chemother (2002) 2.21

Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother (2002) 2.17

Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J Clin Microbiol (2004) 2.07

Emergence of ArmA and RmtB aminoglycoside resistance 16S rRNA methylases in Belgium. J Antimicrob Chemother (2007) 2.04

AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 2.04

Resistance of Yersinia pestis to antimicrobial agents. Antimicrob Agents Chemother (2006) 1.97

Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect Dis (2008) 1.96

Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother (2002) 1.94

Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother (2010) 1.89

armA and aminoglycoside resistance in Escherichia coli. Emerg Infect Dis (2005) 1.70

VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2009) 1.64

The vanG glycopeptide resistance operon from Enterococcus faecalis revisited. Mol Microbiol (2003) 1.64

Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 1.58

Glycopeptide antibiotics: from conventional molecules to new derivatives. Drugs (2004) 1.56

Revised nomenclature for transposable genetic elements. Plasmid (2008) 1.50

RmtF, a new member of the aminoglycoside resistance 16S rRNA N7 G1405 methyltransferase family. Antimicrob Agents Chemother (2012) 1.49

Aminoglycoside resistance by ArmA-mediated ribosomal 16S methylation in human bacterial pathogens. J Mol Biol (2006) 1.48

Sequence of conjugative plasmid pIP1206 mediating resistance to aminoglycosides by 16S rRNA methylation and to hydrophilic fluoroquinolones by efflux. Antimicrob Agents Chemother (2008) 1.44

High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis. Thromb Haemost (2015) 1.44

Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proc Natl Acad Sci U S A (2010) 1.44

The apolipoprotein B R3500Q gene mutation in Spanish subjects with a clinical diagnosis of familial hypercholesterolemia. Atherosclerosis (2002) 1.42

Simple and reliable multiplex PCR assay for detection of blaTEM, bla(SHV) and blaOXA-1 genes in Enterobacteriaceae. FEMS Microbiol Lett (2003) 1.42

Spread of an Enterococcus faecalis sequence type 6 (CC2) clone in patients undergoing selective decontamination of the digestive tract. APMIS (2015) 1.40

European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. J Antimicrob Chemother (2003) 1.40

Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2009) 1.38

Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray. Antimicrob Agents Chemother (2009) 1.36

GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.36

Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections. J Infect Dis (2013) 1.32

A six amino acid deletion, partially overlapping the VanSB G2 ATP-binding motif, leads to constitutive glycopeptide resistance in VanB-type Enterococcus faecium. Mol Microbiol (2003) 1.24

Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrob Agents Chemother (2005) 1.22

VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother (2004) 1.22

Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes. Antimicrob Agents Chemother (2003) 1.22

RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob Agents Chemother (2013) 1.20

D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother (2011) 1.20

Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine. Antimicrob Agents Chemother (2005) 1.19

Chromosomal integration of the extended-spectrum beta-lactamase gene blaCTX-M-15 in Salmonella enterica serotype Concord isolates from internationally adopted children. Antimicrob Agents Chemother (2009) 1.18

Structural bases for 16 S rRNA methylation catalyzed by ArmA and RmtB methyltransferases. J Mol Biol (2009) 1.17

Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon. Antimicrob Agents Chemother (2006) 1.17

rpoB mutation conferring rifampin resistance in Streptococcus pyogenes. Antimicrob Agents Chemother (2002) 1.15

Acquisition of multidrug resistance transposon Tn6061 and IS6100-mediated large chromosomal inversions in Pseudomonas aeruginosa clinical isolates. Microbiology (2010) 1.12

Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice. Infect Immun (2005) 1.10

VanD-type vancomycin-resistant Enterococcus faecium 10/96A. Antimicrob Agents Chemother (2003) 1.09

Organic and conventional fruits and vegetables contain equivalent counts of Gram-negative bacteria expressing resistance to antibacterial agents. Environ Microbiol (2009) 1.08

Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2004) 1.08

Expert systems in clinical microbiology. Clin Microbiol Rev (2011) 1.07

The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? Clin Infect Dis (2002) 1.04

Expression of the resistance-nodulation-cell division pump AdeIJK in Acinetobacter baumannii is regulated by AdeN, a TetR-type regulator. Antimicrob Agents Chemother (2012) 1.04

Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem (2005) 1.02

Development of ertapenem resistance in a patient with mediastinitis caused by Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. J Med Microbiol (2010) 1.01

vanE gene cluster of vancomycin-resistant Enterococcus faecalis BM4405. J Bacteriol (2002) 1.00

Wild-type intracellular bacteria deliver DNA into mammalian cells. Cell Microbiol (2002) 0.97

Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae. J Antimicrob Chemother (2010) 0.95

Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002. Antimicrob Agents Chemother (2004) 0.95

Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR. Hum Mutat (2004) 0.95

parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513. Antimicrob Agents Chemother (2002) 0.95

Binding sites of VanRB and sigma70 RNA polymerase in the vanB vancomycin resistance operon of Enterococcus faecium BM4524. Mol Microbiol (2005) 0.95

Antimicrobial resistance of Listeria monocytogenes isolates from food and the environment in France over a 10-year period. Appl Environ Microbiol (2011) 0.94

An emptying quiver: antimicrobial drugs and resistance. Emerg Infect Dis (2005) 0.93

Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure. MBio (2014) 0.93

Plasmid-mediated quinolone resistance in expanded spectrum beta lactamase producing enterobacteriaceae in Morocco. J Infect Dev Ctries (2010) 0.93

Comparison of four methods, including semi-automated rep-PCR, for the typing of vancomycin-resistant Enterococcus faecium. J Microbiol Methods (2010) 0.92

Aminoglycoside resistance gene ant(4')-IIb of Pseudomonas aeruginosa BM4492, a clinical isolate from Bulgaria. Antimicrob Agents Chemother (2003) 0.92

Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp. Antimicrob Agents Chemother (2013) 0.92

Omega-3 fatty acids and blood pressure. Br J Nutr (2012) 0.91

Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria. Clin Microbiol Infect (1996) 0.91

VanA-mediated high level glycopeptide resistance in MRSA. Lancet Infect Dis (2003) 0.91

Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients. Thromb Haemost (2013) 0.90

Structural basis of Synercid (quinupristin-dalfopristin) resistance in Gram-positive bacterial pathogens. J Biol Chem (2003) 0.90

Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis. Antimicrob Agents Chemother (2006) 0.90

Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. Thromb Haemost (2013) 0.89

Higher incidence of mild cognitive impairment in familial hypercholesterolemia. Am J Med (2010) 0.89

VanA-type Staphylococcus aureus strain VRSA-7 is partially dependent on vancomycin for growth. Antimicrob Agents Chemother (2009) 0.89

Glycopeptide resistance vanA operons in Paenibacillus strains isolated from soil. Antimicrob Agents Chemother (2005) 0.89

The functional vanGCd cluster of Clostridium difficile does not confer vancomycin resistance. Mol Microbiol (2013) 0.88

Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes. J Clin Microbiol (2005) 0.87

RAHN-2, a chromosomal extended-spectrum class A beta-lactamase from Rahnella aquatilis. J Antimicrob Chemother (2010) 0.87

Resistance phenotypes conferred by macrolide phosphotransferases. FEMS Microbiol Lett (2007) 0.87

Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects. Semin Vasc Med (2004) 0.86

Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities. Atherosclerosis (2012) 0.86

Chromosomal aadD2 encodes an aminoglycoside nucleotidyltransferase in Bacillus clausii. Antimicrob Agents Chemother (2003) 0.85

LRP1 gene polymorphisms are associated with premature risk of cardiovascular disease in patients with familial hypercholesterolemia. Rev Esp Cardiol (Engl Ed) (2012) 0.85

Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation. Arterioscler Thromb Vasc Biol (2005) 0.85

Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin. Antimicrob Agents Chemother (2008) 0.85

Transcriptional analysis of the vanC cluster from Enterococcus gallinarum strains with constitutive and inducible vancomycin resistance. Antimicrob Agents Chemother (2005) 0.85